EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® ...

Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

The final trades of the day with the Fast Money traders.

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States, the second in a wave of near-copies of the ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

As Hamas handed over the bodies of four murdered hostages, Israelis gathered in grief, marking a painful moment in the ...

J. Bradley White has been named managing partner of Osler, Hoskin & Harcourt LLP’s Ottawa office. He took the post on January ...

Mr. Trump has said he wants Canada and Mexico to stop the flow of migrants at the border and curtail shipments of fentanyl. But at least publicly, he has offered only vague benchmarks to gauge ...

The impacts of climate change are increasingly visible across Canada. The Government of Canada is working to make Canada’s transportation system greener, to build more resilient supply chains, build a ...

In Canada, salbutamol is marketed in nebules, metered-dose inhalers, respiratory solutions and injectable formats. Pharmascience Inc. and Teva Canada Ltd. market the nebules and are both reporting ...

Anna Triandafyllidou receives funding from the Social Sciences and Humanities Research Council of Canada (SSHRC) and the Tri-Agency Council of Canada. Toronto Metropolitan University provides ...